ASTRAZEN.BOASTRAZEN.BOBSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank57
5Y CAGR-21.2%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
-21.2%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202524.82%
202415.14%
2023113.77%
2022-40.09%
202113.36%
202081.91%
201965.24%
201815.19%
20174413.06%
201697.03%